The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions
Open accessAbstract
Chronic active multiple sclerosis lesions, characterized by a hyperintense rim of iron-enriched, activated microglia and macrophages, have been linked to greater tissue damage. Post-mortem studies have determined that chronic active lesions are primarily related to the later stages of multiple sclerosis; however, the occurrence of these lesions, and their relationship to earlier disease stages may be greatly underestimated. Detection of chronic active lesions across the patient spectrum of multiple sclerosis requires a validated imaging tool to accurately identify lesions with persistent inflammation. Quantitative susceptibility mapping provides efficient in vivo quantification of susceptibility changes related to iron deposition and the potential to identify lesions harbouring iron-laden inflammatory cells. The PET tracer 11C-PK11195 targets the translocator protein expressed by activated microglia and infiltrating macrophages. Accordingly, this study aimed to validate that lesions with a hyperintense rim on quantitative susceptibility mapping from both relapsing and progressive patients demonstrate a higher level of innate immune activation as measured on 11C-PK11195 PET. Thirty patients were enrolled in this study, 24 patients had relapsing remitting multiple sclerosis, six had progressive multiple sclerosis, and all patients had concomitant MRI with a gradient echo sequence and PET with 11C-PK11195. A total of 406 chronic lesions were detected, and 43 chronic lesions with a hyperintense rim on quantitative susceptibility mapping were identified as rim+ lesions. Susceptibility (relative to CSF) was higher in rim+ (2.42 ± 17.45 ppb) compared to rim- lesions (-14.6 ± 19.3 ppb, P < 0.0001). Among rim+ lesions, susceptibility within the rim (20.04 ± 14.28 ppb) was significantly higher compared to the core (-5.49 ± 14.44 ppb, P < 0.0001), consistent with the presence of iron. In a mixed-effects model, 11C-PK11195 uptake, representing activated microglia/macrophages, was higher in rim+ lesions compared to rim- lesions (P = 0.015). Validating our in vivo imaging results, multiple sclerosis brain slabs were imaged with quantitative susceptibility mapping and processed for immunohistochemistry. These results showed a positive translocator protein signal throughout the expansive hyperintense border of rim+ lesions, which co-localized with iron containing CD68+ microglia and macrophages. In conclusion, this study provides evidence that suggests that a hyperintense rim on quantitative susceptibility measure within a chronic lesion is a correlate for persistent inflammatory activity and that these lesions can be identified in the relapsing patients. Utilizing quantitative susceptibility measure to differentiate chronic multiple sclerosis lesion subtypes, especially chronic active lesions, would provide a method to assess the impact of these lesions on disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This suggests that the TSPO PET signal arises from astrocytes as well as microglia, which is consistent with reports that newer generation ligands for TSPO bind to reactive astrocytes (Dickens et al., 2014; Kaunzner et al., 2019).”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Kaunzner et al., 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Similar to a recent study combining quantitative susceptibility mapping and immunohistochemistry (Kaunzner et al., 2019), our studies revealed non-trivial expression of TSPO in astrocytes in all subtypes of lesions examined.”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as Kaunzner et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., HITZEMANN, R. J., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,481
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker
Wang, Y., & Liu, T. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25358 · Cited by 878
Self-citationFrischer, J. M., Weigand, S. D., Guo, Y., Kale, N., Parisi, J. E., Pirko, I., Mandrekar, J., Bramow, S., Metz, I., Brück, W., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24497 · Cited by 728
de Rochefort, L., Liu, T., Kressler, B., Liu, J., Spincemaille, P., Lebon, V., Wu, J., & Wang, Y. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22187 · Cited by 672
Self-citationThe peripheral benzodiazepine binding site in the brain in multiple sclerosis
Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., et al. (2000) · Brain · doi:10.1093/brain/123.11.2321 · Cited by 661
Iron and neurodegeneration in the multiple sclerosis brain
Hametner, S., Wimmer, I., Haider, L., Pfeifenbring, S., Brück, W., & Lassmann, H. (2013) · Annals of Neurology · doi:10.1002/ana.23974 · Cited by 519
Quantitative MR Imaging of Brain Iron: A Postmortem Validation Study
Langkammer, C., Krebs, N., Goessler, W., Scheurer, E., Ebner, F., Yen, K., Fazekas, F., & Ropele, S. (2010) · Radiology · doi:10.1148/radiol.10100495 · Cited by 508
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–199 of 199
Kor, D., Jbabdi, S., Huszár, I. N., Mollink, J., Tendler, B. C., Foxley, S., Wang, C., Scott, C., Smart, A., Ansorge, O., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119726 · Cited by 14
Singhal, T., Cicero, S., Rissanen, E., Ficke, J., Kukreja, P., Vaquerano, S., Glanz, B. I., Dubey, S., Sticka, W., Seaver, K., et al. (2024) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000005201 · Cited by 11
Elkady, A. M., Elliott, C., Fetco, D., Araújo, D., Karimaghaloo, Z., Ganzetti, M., Clayton, D., Craveiro, L., Kazlauskaite, A., Narayanan, S., et al. (2024) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29583 · Cited by 12
Bulk, M., van Harten, T. W., Kenkhuis, B., Inglese, F., Hegeman, I. M., van Duinen, S. G., Ercan, E., Checa, C. M., Goeman, J. J., Mawrin, C., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102637 · Cited by 11
Ndayisaba, A., Pitaro, A. T., Willett, A. S., Jones, K. A., de Gusmão, C. M., Olsen, A. L., Kim, J., Rissanen, E., Woods, J. K., Srinivasan, S. R., et al. (2022) · The Cerebellum · doi:10.1007/s12311-022-01471-8 · Cited by 11
Krajnc, N., Dal‐Bianco, A., Leutmezer, F., Kasprian, G. J., Pemp, B., Kornek, B., Berger, T., Rommer, P. S., Hametner, S., Lassmann, H., et al. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585221138486 · Cited by 11
Kang, Y., Rúa, S., Kaunzner, U., Perumal, J., Nealon, N., Qu, W.-C., Kothari, P., Vartanian, T., Kuceyeski, A., & Gauthier, S. (2020) · Molecular Imaging and Biology · doi:10.1007/s11307-020-01501-z · Cited by 9
Self-citationKrajnc, N., Hofer, L., Föttinger, F., Dal‐Bianco, A., Leutmezer, F., Kornek, B., Rommer, P. S., Kasprian, G. J., Berger, T., Pemp, B., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16529 · Cited by 10
Zivadinov, R., Schweser, F., Dwyer, M. G., & Pol, S. (2020) · Journal of Neuroimaging · doi:10.1111/jon.12768 · Cited by 9
Susceptibility-weighted image features in AQP4-negative-NMOSD versus MS
Gao, C., Su, L., Li, H., Song, T., Liu, Y., Duan, Y., & Shi, F. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105406 · Cited by 10
Treaba, C. A., Herranz, E., Barletta, V. T., Mehndiratta, A., Sloane, J. A., Granberg, T., Miscioscia, A., Bomprezzi, R., Loggia, M. L., & Mainero, C. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241284157 · Cited by 9
Ye, H., Shaghaghi, M., Chen, Q., Zhang, Y., Lutz, S. E., Chen, W., & Cai, K. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27363 · Cited by 9
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis
Krajnc, N., Bsteh, G., Kasprian, G. J., Zrzavy, T., Kornek, B., Berger, T., Leutmezer, F., Rommer, P. S., Lassmann, H., Hametner, S., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.928582 · Cited by 9
Venous Diameter Changes in Chronic Active Multiple Sclerosis Lesions
Weber, C. E., Kraemer, M., Dabringhaus, A., Ebert, A., Platten, M., Gass, A., & Eisele, P. (2020) · Journal of Neuroimaging · doi:10.1111/jon.12818 · Cited by 9
Mistry, N., Hobart, J. C., Rog, D. J., Muhlert, N., Mathews, J., Baker, D., & Giovannoni, G. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105706 · Cited by 9
Typical and Emerging Diagnostic MRI Features in Multiple Sclerosis
Rovira, À., Auger, C., Sceppacuercia, S., & Torres, C. (2024) · Canadian Association of Radiologists Journal · doi:10.1177/08465371241261847 · Cited by 10
Clinical relevance of paramagnetic rim lesion heterogeneity in multiple sclerosis
Stölting, A., Bulcke, C. V., Borrelli, S., Bugli, C., Pasquier, R. D., Pesch, V. V., & Maggi, P. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52220 · Cited by 8
Verma, S., Goel, T., & Tanveer, M. (2022) · Cognitive Computation · doi:10.1007/s12559-022-10095-3 · Cited by 7
Non-invasive in vivo imaging of brain and retinal microglia in neurodegenerative diseases
Etebar, F., Harkin, D. G., White, A. R., & Dando, S. J. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1355557 · Cited by 7
Lipka, A., Bogner, W., Dal‐Bianco, A., Hangel, G. J., Rommer, P. S., Strasser, B., Motyka, S., Hingerl, L., Berger, T., Leutmezer, F., et al. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103524 · Cited by 6
More than microglia: myeloid cells and biomarkers in neurodegeneration
Kodosaki, E., Bell, R., Sogorb‐Esteve, A., Wiltshire, K., Zetterberg, H., & Heslegrave, A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1499458 · Cited by 6
Klistorner, S., Usnich, T., Clarke, M. A., Pareto, D., Rovira, À., Paul, F., Barnett, M. H., & Klistorner, A. I. (2025) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/20552173251378788 · Cited by 6
Zhang, J., Zuo, L., Dewey, B. E., Remedios, S. W., Liu, Y., Hays, S. P., Pham, D. L., Mowry, E. M., Newsome, S. D., Calabresi, P. A., et al. (2026) · Medical Image Analysis · doi:10.1016/j.media.2026.103954 · Cited by 6
Wang, M., Yang, X., Liu, D., Dang, P., Huang, X., Zheng, J., Ding, F., Ding, X., & Wang, X. (2023) · Clinical Radiology · doi:10.1016/j.crad.2023.11.007 · Cited by 6
Xie, Y. H., Zhang, S., Wu, D., Yao, Y., Cho, J., Lü, J., Zhu, H., Wang, Y., Zhang, Y., & Zhu, W. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07463-2 · Cited by 7
Self-citationAntigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis
Li, V., Binder, M. D., Purcell, A. W., & Kilpatrick, T. J. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578347 · Cited by 7
Basilar artery thrombus magnetic susceptibility for cardioembolic stroke identification
Chen, J., Zhang, Z., Nie, X., Xu, Y., Liu, C., Zhao, X., & Wang, Y. (2021) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-21-547 · Cited by 6
Self-citationSWI as an Alternative to Contrast-Enhanced Imaging to Detect Acute MS Lesions
Caruana, G., Auger, C., Pessini, L. M., Calderon, W., de Barros, A., Salerno, A., Sastre‐Garriga, J., Montalbán, X., & Rovira, À. (2022) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7474 · Cited by 6
Tyler, S. E. B., & Tyler, L. D. K. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100094 · Cited by 6
Impact of paramagnetic rim lesions on disability and race in multiple sclerosis: mediation analysis
Michaelson, N. M., Rúa, S. M. H., Kaunzner, U. W., Marcille, M., Pliska‐Bloch, I., Markowitz, K. H., Nguyen, T. D., & Gauthier, S. A. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52203 · Cited by 6
Self-citationLiu, X., Wang, Y., Wei, N., Zhu, W., Suo, Y., Xu, Y., Jin, A., Xu, Q., Qi, N., Jiang, Q., et al. (2025) · Multiple Sclerosis Journal · doi:10.1177/13524585251328902 · Cited by 5
Self-citationAdvances in neuroimaging applications of quantitative susceptibility mapping
Ma, S., Fu, W., Chai, C., Wang, H., Lv, K., Zhao, C., Haacke, E. M., Buch, S., & Xia, S. (2025) · Meta-Radiology · doi:10.1016/j.metrad.2025.100148 · Cited by 5
Paramagnetic rim lesions in early multiple sclerosis: a 7 Tesla imaging study
Kazimuddin, H. F., Wang, J., Toubasi, A. A., Hernandez, B., Sun, L., Vinarsky, T., Gheen, C., Rohm, Z., Koch, C. E., Eaton, J. E., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf215 · Cited by 7
Lus, G., Bassano, M. A., Morra, V. B., Bonavita, S., Gallo, A., Maimone, D., Malerba, L., Maniscalco, G. T., Saccà, F., Salemi, G., et al. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06402-3 · Cited by 5
Molecular mechanisms associated with multiple sclerosis progression, severity and phenotypePreprint
Kosa, P. F., Lumbard, K., Wang, J., Liang, C., Masvekar, R., Kim, Y., Varosanec, M., Jennings, L. L., & Bielekova, B. (2022) · medRxiv · doi:10.1101/2022.10.14.22281095 · Cited by 5
DeDA: Deep Directed Accumulator
Zhang, H., Wang, R., Hu, R., Zhang, J., & Li, J. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-43895-0_72 · Cited by 4
Tozlu, C., Jamison, K. W., Kang, Y., Rúa, S. M. H., Kaunzner, U. W., Nguyen, T., Kuceyeski, A. F., & Gauthier, D. S. A. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1107 · Cited by 4
Self-citationToward In Vivo MRI of the Tissue Proton Exchange Rate in Humans
Shaghaghi, M., & Cai, K. (2022) · Biosensors · doi:10.3390/bios12100815 · Cited by 4
Moura, J., Granziera, C., Marta, M., & SILVA, A. C. F. D. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07402-1 · Cited by 5
Chitnis, T., Singhal, T., Zurawski, J. D., Saraceno, T. J., Gopalakrishnan, N., Cain, L., LaBarre, B. A., King, D. A., Bergmark, R. W., Maxfield, A. Z., et al. (2025) · medRxiv · doi:10.1101/2025.04.30.25326602 · Cited by 4
Imaging Outcomes for Phase 2 Trials Targeting Compartmentalized Inflammation
Gaitán, M. I., Márquez, R., Ayerbe, J., & Reich, D. S. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241301303 · Cited by 3
Motamed-Gorji, N., Bahrami, A., Taher, H. J., Easa, A. M., Salehi, S., Tafazolimoghadam, A., Farzan, M., Sadeghi, Z., Mofidinaeini, S., Hajibeygi, R., et al. (2025) · Neuroradiology · doi:10.1007/s00234-025-03663-5 · Cited by 3
Chitnis, T., Singhal, T., Zurawski, J. D., Saraceno, T. J., Gopalakrishnan, N., Cain, L., LaBarre, B. A., King, D. A., Bergmark, R. W., Maxfield, A. Z., et al. (2026) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200543 · Cited by 7
Hosseini, S. A., Servaes, S., Macedo, A. C., Aumont, É., Rahmouni, N., Chan, T., Therriault, J., Trudel, L., Hall, B. J., Wang, Y., et al. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261417193 · Cited by 3
Self-citationChronic lesion expansion as an imaging biomarker in multiple sclerosis
Hayes, M., Beadnall, H. N., Merlo, D., Monif, M., Klistorner, S., Zhu, C., van der Walt, A., & Butzkueven, H. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107093 · Cited by 4
ISMRM Clinical Focus Meeting 2023: “Imaging the Fire in the Brain”
Agarwal, N., Fan, A. P., Huang, X., Dehkharghani, S., & van der Kolk, A. G. (2024) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29587 · Cited by 3
Advanced MRI Measures of Myelin and Axon Volume Identify Repair in Multiple Sclerosis
Sanabria-Díaz, G., Cagol, A., Lu, P., Baraković, M., Ocampo‐Pineda, M., Chen, X., Weigel, M., Ruberte, E., Siebenborn, N. D. O. S., Galbusera, R., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27102 · Cited by 4
Treadmill Training-Induced Remyelination Rescues Cognitive Impairment After Acute Hypoxia
Zhang, Q., Xu, Y., Luo, H., Su, H., Zhong, J., Pan, L., Liu, Y., Yang, C., Yin, Y., & Tan, B. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04359-1 · Cited by 3
Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple SclerosisPreprint
Markowitz, K. H., Safi, N. V., Dimov, A., Kaunzner, U. W., Luu, H. M., Şişman, M., Wang, Y., Nguyen, T. D., Rúa, S. M. H., & Gauthier, S. A. (2025) · medRxiv · doi:10.1101/2025.05.20.25328011 · Cited by 3
Self-citationSkattebøl, L., Lundby, R., Øverås, M. H., Sowa, P., Celius, E. G., Harbo, H. F., Nordhøy, W., Høgestøl, E. A., & Nygaard, G. O. (2025) · Neuroimage Reports · doi:10.1016/j.ynirp.2025.100277 · Cited by 2
Gkotsoulias, D., Weigel, M., Cagol, A., Siebenborn, N. D. O. S., Ruberte, E., Pfeuffer, J., & Granziera, C. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1544376 · Cited by 2
Shi, Z., Wang, H., Yan, Z., Tang, Y., Moccia, M., Nie, L., Wei, H., Lin, B., Hu, H., Yin, F., et al. (2025) · Multiple Sclerosis Journal · doi:10.1177/13524585251389809 · Cited by 2
Preziosa, P., Guido, G., Filippi, M., & Rocca, M. A. (2026) · Neurology and Therapy · doi:10.1007/s40120-026-00931-1 · Cited by 2
Erythrocyte Fragility in Progressive Multiple Sclerosis
Jacob, C., Williams, T. E., Stuart, C. M., Witkover, A., Hametner, S., Lassmann, H., Bangham, C. R. M., Chataway, J., & Galea, I. (2026) · European Journal of Neurology · doi:10.1111/ene.70595 · Cited by 2
Matrosova, M. S., Bryukhov, V. V., Popova, E. V., Belskaya, G. N., & Кротенкова, М. В. (2023) · Medical Visualization · doi:10.24835/1607-0763-1256 · Cited by 3
Paramagnetic rim sign in multiple sclerosis
Kapkanets, D. V., Belov, S. E., Dolgushin, M. B., & Boyko, A. N. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-4-94-99 · Cited by 2
The Presence of a Paramagnetic Phase Rim is Linked to Lesion Age in Multiple SclerosisPreprint
Klistorner, S., Usnich, T., Clarke, M. A., Pareto, D., Rovira, À., Paul, F., Barnett, M. H., & Klistorner, A. I. (2025) · medRxiv · doi:10.1101/2025.01.12.25320426 · Cited by 2
Tsai, H., Piya, S., Wang, J., Zhu, J. K., Hu, W., Gehrke, A. R., Cao, S., Guise, A. J., Chan, S. J., Sheehan, M. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.07.637125 · Cited by 2
Doorduin, J. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19104-6.00016-4 · Cited by 1
Schlaeger, S., Mühlau, M., Gilbert, G., Vavasour, I. M., Amthor, T., Doneva, M., Menegaux, A., Álvarez, M. G. M., Lauerer, M., Pongratz, V., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318415 · Cited by 1
Insights From Quantitative Susceptibility Mapping: An Umbrella Review of Multiple Sclerosis
Ghaderi, S., Mohammadi, S., & Fatehi, F. (2026) · Health Science Reports · doi:10.1002/hsr2.72003 · Cited by 1
Callot, V., Destruel, A., Demortière, S., & Testud, B. (2026) · Revue Neurologique · doi:10.1016/j.neurol.2026.04.003 · Cited by 1
The Prognostic Value of Paramagnetic Rim Lesions in People With Multiple Sclerosis
Lauerer, M., Voon, C. C., McGinnis, J., Sepp, D., Meineke, J., Wiltgen, T., Berg, R., Preibisch, C., Wiestler, B., Engl, C., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000218428 · Cited by 1
Asadollahzadeh, E., Razmara, R., Shahmaei, V., Sodaei, F., Rezaei, A., Hamidi, M., zahirmirdamadi, H., Lapevandani, M. M., Ghafari, A., Samadzadeh, S., et al. (2026) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.70491 · Cited by 1
He, L., Tang, S., Zhang, G., Liu, X., & Chen, Z. (2022) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405618666220325090655 · Cited by 1
Mantovani, D. B. A., Pitombeira, M., Schuck, P., de Araújo, A. S., Buchpiguel, C., Faria, D. D. P., & da Silva, A. D. (2024) · Journal of Imaging · doi:10.3390/jimaging10020039 · Cited by 1
Saab, G., & Khoury, S. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00061-8 · Cited by 1
Smolders, J., Hamann, J., & Huitinga, I. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90242-7.00016-x · Cited by 1
Crescenzo, F., Marastoni, D., Pisani, A. I., Tamanti, A., Dapor, C., Colombi, A., Brillo, A., Magliozzi, R., Pizzini, F. B., Castellaro, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11040686 · Cited by 1
Zhang, Y. (2024) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29585 · Cited by 1
Cortical morphology predicts placebo response in multiple sclerosisPreprint
Cherkasova, M. V., Fu, J. F., Jarrett, M., Johnson, P., Abel, S., Tam, R. C., Rauscher, A., Sossi, V., Kolind, S., Li, D. K. B., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/825638
Technical Note: Optimization of quantitative susceptibility mapping by streaking artifact detection
Wu, M., Wang, C., Lin, P., & Chao, T. C. (2020) · Medical Physics · doi:10.1002/mp.14460
Über die Rolle von Eisen bei multipler Sklerose
Hametner, S. (2021) · psychopraxis neuropraxis · doi:10.1007/s00739-021-00707-2
Huang, W., Sweeney, E. M., Kaunzner, U. W., Wang, Y., Gauthier, S. A., & Nguyen, T. D. (2021) · medRxiv · doi:10.1101/2021.05.23.21257680
Self-citationDuque‐Wilckens, N., Sarno, E., Teis, R. E., Stölting, F., Khalid, S., Dairi, Z., Douma, A., Maradiaga, N. C., Thelen, K. M., Robison, A. J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.17.460793
Matrosova, M. S., Bryukhov, V. V., Belskaya, G. N., & Кротенкова, М. В. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212212116
(2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-91771-1.00006-x
Molecular and tissue basis of neuroinflammation in health and disease
(2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-91771-1.00002-2
Imagem PET de processos relacionados à esclerose múltipla: estudo clínico
Pitombeira, M. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-20042023-115057
Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
Yang, J. (2023) · Journal of Multiple Sclerosis and Neuroimmunology · doi:10.59578/jmsni.2023.14.1.1
Mainero, C., & Treaba, C. A. (2023) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-323-99898-7.00024-9
Singhal, T., Cicero, S., Rissanen, E., Ficke, J., Kukreja, P., Vaquerano, S., Glanz, B. I., Dubey, S., Sticka, W., Seaver, K., et al. (2023) · medRxiv · doi:10.1101/2023.10.06.23295721
Matrosova, M. S., Bryukhov, V. V., Popova, E. V., Belskaya, G. N., & Кротенкова, М. В. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-6-48-55 · Cited by 1
Šišić, N., Baraković, M., Almisreb, A. A., Granziera, C., & Peter, R. (2024) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-031-49062-0_70
Manasseh, G., Hilbert, T., Fartaria, M. J., Deverdun, J., Cuadra, M. B., Maréchal, B., Kober, T., & Dunet, V. (2024) · Diagnostics · doi:10.3390/diagnostics14232669
Quantitative susceptibility mapping in multiple sclerosis
Schweser, F., & Rauscher, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95739-7.00027-7
Magnetic resonance imaging physics and image acquisition
Cho, J., & Dimov, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95739-7.00007-1
Magnetic resonance imaging of the multiple sclerosis lesions
Calabrese, M., & Tamanti, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95739-7.00012-5
Use of artificial intelligence in multiple sclerosis imaging
Tozlu, C., Kuceyeski, A. F., & Dwyer, M. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95739-7.00015-0
Positron emission tomography imaging in multiple sclerosis
Cicero, S., Hansel, C., Rissanen, E., & Singhal, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95739-7.00019-8
Central vein sign and iron rim sign in multiple sclerosis
Burgetová, A., Dušek, P., Burgetová, R., Pudlač, A., & Lambert, L. (2021) · Česká radiologie · doi:10.55095/cesradiol2021/035
Update on MRI Biomarkers in Multiple Sclerosis
Kim, N. (2025) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2025.0012
Tang, Y., Wang, H., Wang, X., Yan, Z., Zhu, Q., Yin, T., Xu, Y., Wei, Y., Yang, B., Shi, Z., et al. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578738
Additional file 1 of Iron deposition in multiple sclerosis: overall load or distribution alteration?
Hamdy, E., Galeel, A. A., Ramadan, I., Gaber, D. E., Mustafa, H., & Mekky, J. (2022) · Figshare · doi:10.6084/m9.figshare.21069384
Study protocol for the Champaign-Urbana population study
Camacho, P., Anderson, A. T., Guo, R., Chai, Y., Tafti, S., Hall, I. R., Pindus, D. M., Lockwood, C., Arnold, P. M., Anteraper, S. A., et al. (2026) · Frontiers in Neuroimaging · doi:10.3389/fnimg.2026.1728970
Tsai, H., Piya, S., Wang, J., Zhu, J., Hu, W., Gehrke, A. R., Cao, S., Guise, A. J., Chan, S. J., Sheehan, M. J., et al. (2026) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2026.1832826 · Cited by 2
Evaluating the Clinical Utility of TSPO-PET in MS and the Influence of Methodological Heterogeneity
Neishaboori, A. M., Agarwal, M., Kalinsky, A., Lofaso, J. P., Rampilla, G., Kras, E. A., Nagy, S. C., Cooper, J. G., Ai, S., Zhang, C. K., et al. (2026) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200658
Altered Glutamate Homeostasis in Paramagnetic Rim Lesions of Patients with Multiple Sclerosis
Jacobs, P. S., Spangler, B. C., Bakhtiar, N., Elkady, A. M., Wilson, N. E., Swain, A., Horwath, E. A., Awad, M., Yamashita, L. D., Shinohara, R. T., et al. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1406
Metadata
- Authors
- Kaunzner, U. W., Kang, Y., Zhang, S., Morris, E., Yao, Y., Pandya, S., Hurtado Rua, S. M., Park, C., Gillen, K. M., Nguyen, T. D., Wang, Y., Pitt, D., & Gauthier, S. A.
- Affiliations
- Weill Cornell Medicine (US)
- Cornell MRI Research Lab, New York City, NY, USA
- Department of Mathematics, College of Sciences and Health Professions, Cleveland State University, Cleveland, OH, USA
- Yale University (US)
- Corresponding author
- Gauthier, Susan A
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-12-15
- Volume
- 142
- Issue
- 1
- Pages
- 133-145
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6308309
- OpenAlex
- W2904004727
- Cited by
- 199
- References
- 63
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 40 · 2023: 27 · 2022: 33 · 2021: 30 · 2020: 23 · 2019: 11
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EngagedScholarship @ Cleveland State University (Cleveland State University) (submittedVersion)
- Funders
- National Institutes of Health (RO1 NS090464)
- Biogen (55000025)
- Genzyme (56585757)
- Novartis (56585786, UL1 TR000456-06)
- Weill Cornell Clinical and Translational Science Center
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- chronic active lesions, quantitative susceptibility mapping, [11C]PK11195, translocator protein (TSPO), microglial activation, macrophages, iron accumulation, innate immune activation, relapsing-remitting multiple sclerosis, progressive multiple sclerosis, CD68, immunohistochemistry
- MeSH terms
- CD68 Molecule, Adult, Aged, Brain, Carbon Radioisotopes, Chronic Disease, Cross-Sectional Studies, Female, Humans, Inflammation, Iron, Isoquinolines, Macrophages, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Retrospective Studies, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Microglia, Positron-Emission Tomography, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review